Table 4.
Relationships of PPARα and LPL genotypes with lipid concentrations in the study population
| Lipid | PPARα | LPL | |||||
|---|---|---|---|---|---|---|---|
| GG | GC+CC | P | TT | TG | GG | P | |
| TG (mmol/L) | 1.58 ± 0.67 | 1.41 ± 0.61 | 0.013* | 1.67 ± 0.77 | 1.44 ± 0.56 | 1.59 ± 0.72 | 0.017* |
| HDL-C (mmol/L) | 0.86 ± 0.18 | 0.85 ± 0.15 | 0.619 | 0.87 ± 0.18 | 0.86 ± 0.16 | 0.92 ± 0.11 | 0.012* |
| TC (mmol/L) | 4.30 ± 0.76 | 4.45 ± 0.65 | 0.042* | 4.26 ± 0.79 | 4.32 ± 0.76 | 4.44 ± 0.75 | 0.151 |
| LDL-C (mmol/L) | 2.58 ± 0.61 | 2.74 ± 0.53 | 0.014* | 2.57 ± 0.51 | 2.63 ± 0.46 | 2.67 ± 0.42 | 0.164 |
Values are presented as mean±standard deviation.
*P<0.05.
PPARα, peroxisome proliferator-activated receptor α; LPL, lipoprotein lipase enzyme; G, guanine; C, cytosine; T, thymine; TG, triglyceride; HDL-C, highdensity lipoprotein cholesterol; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol.